Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Usana Health Sciences (USNA) Tax Provisions (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Tax Provisions for 17 consecutive years, with $5.8 million as the latest value for Q1 2026.

  • Quarterly Tax Provisions fell 2.91% to $5.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $30.0 million through Jan 2026, down 12.37% year-over-year, with the annual reading at $30.0 million for FY2026, 12.37% down from the prior year.
  • Tax Provisions for Q1 2026 was $5.8 million at Usana Health Sciences, down from $8.5 million in the prior quarter.
  • The five-year high for Tax Provisions was $57.0 million in Q1 2022, with the low at $5.8 million in Q1 2026.
  • Average Tax Provisions over 5 years is $11.8 million, with a median of $9.4 million recorded in 2023.
  • The sharpest move saw Tax Provisions grew 10.72% in 2023, then tumbled 39.61% in 2024.
  • Over 5 years, Tax Provisions stood at $8.3 million in 2022, then rose by 18.69% to $9.8 million in 2023, then crashed by 39.61% to $5.9 million in 2024, then skyrocketed by 42.24% to $8.5 million in 2025, then crashed by 31.74% to $5.8 million in 2026.
  • According to Business Quant data, Tax Provisions over the past three periods came in at $5.8 million, $8.5 million, and $8.4 million for Q1 2026, Q3 2025, and Q2 2025 respectively.